Obalon Therapeutics Inc.

Obalon Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.67
Market Cap
$21.05 M
Shares Outstanding
34.79 M
Public Float
10.5 M

Profile

Address
5421 Avenida Encinas
Carlsbad California 92008
United States
Employees -
Website http://www.obalon.com
Updated 07/08/2019
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded in January 2008 and is headquartered in San Diego, CA.

Financials

View All

Andrew P. Rasdal
Chief Executive Officer & Director
David Moatazedi
Director